Loading...

Kuros Biosciences AG

KURN.SWSIX
HealthcareBiotechnology
CHF24.80
CHF-0.12(-0.48%)

Kuros Biosciences AG KURN.SW Peers

See (KURN.SW) competitors and their performances in Stock Market.

Peer Comparison Table: Biotechnology Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
KURN.SWCHF 24.80-0.48%951.9M-248.00-CHF 0.10N/A
MOR.SWCHF 102.00-100.00%2.4B-4.03-CHF 25.33N/A
BION.SWCHF 30.70-0.49%1.7B13.41CHF 2.29+5.86%
BSLN.SWCHF 49.20+6.15%603.8M8.44CHF 5.83N/A
IDIA.SWCHF 2.00N/A407.6M-1.44-CHF 1.39N/A
SANN.SWCHF 13.14-0.15%169.1M-3.56-CHF 3.69N/A
NWRN.SWCHF 7.32N/A146.1M9.15CHF 0.80N/A
MOLN.SWCHF 2.95-2.64%108.8M-1.74-CHF 1.70N/A
RLF.SWCHF 2.21-3.91%27.8M-1.62-CHF 1.36N/A
ADXN.SWCHF 0.06+1.42%10M-1.14-CHF 0.05N/A
Showing 1 to 10 of 16 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

KURN.SW vs MOR.SW Comparison

KURN.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, KURN.SW stands at 951.9M. In comparison, MOR.SW has a market cap of 2.4B. Regarding current trading prices, KURN.SW is priced at CHF 24.80, while MOR.SW trades at CHF 102.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

KURN.SW currently has a P/E ratio of -248.00, whereas MOR.SW's P/E ratio is -4.03. In terms of profitability, KURN.SW's ROE is -0.07%, compared to MOR.SW's ROE of +2.47%. Regarding short-term risk, Volatility data is not available for a full comparison. KURN.SW has daily volatility of 2.10 and MOR.SW has daily volatility of N/A.

Stock Price Comparison

Loading...

Frequently Asked Questions